- EMDR (eye movement desensitisation and reprocessing) is a structured, eight-phase trauma therapy. The person briefly holds an upsetting memory in mind while following a back-and-forth movement, light or tone (US VA National Center for PTSD). Francine Shapiro developed it after a walk in a park in 1987 and published the first report in 1989 (Shapiro 1989).
- For PTSD in adults, EMDR clearly beats waiting lists or usual care. A 2020 systematic review and meta-analysis concluded that trauma-focused CBT and EMDR are both first-line treatments (Lewis et al. 2020).
- Four major guidelines back it for adult PTSD. NICE recommends EMDR for some adults with PTSD (including the timing and preference conditions) (NICE NG116). WHO (2013, updated 2023), ISTSS (2019) and the US VA/DoD (2023) also recommend it (WHO; ISTSS; VA/DoD).
- Whether the eye movements themselves matter is still disputed. A 2001 meta-analysis found no added effect (Davidson & Parker 2001). A 2013 meta-analysis found a moderate added effect (d = 0.41) (Lee & Cuijpers 2013); its first author is listed as a trainer at an EMDR training company (Psychology Training).
- Outside PTSD the case is weak. A 76-trial review found only 4 of 27 studies at low risk of bias and "not enough evidence" to advise EMDR for other mental health problems (Cuijpers et al. 2020).
- Money trail: the EMDR mark is a registered US service mark of the EMDR Institute, Inc. for professional training seminars (USPTO), which charges licensed clinicians up to $750 per training weekend (EMDR Institute). The newest UK review was funded by the EMDR Association UK (Simpson et al. 2025).
- Evidence grade: Strong for PTSD in adults. Moderate for PTSD in children, where it ranks behind trauma-focused CBT. Weak for phobias and other anxiety problems. Insufficient for depression, pain, addiction and very early use after trauma. Risk of temporary distress, and lab evidence of memory distortion that matters for legal witnesses.
Independent evidence review · Psychological therapy
EMDR is an effective, first-line treatment for PTSD in adults, about as good as trauma-focused CBT, but the eye movements that give it its name may not be the active ingredient. Independent reviews and four national and international guidelines agree on its benefit for PTSD, although most individual trials are small and at high or unclear risk of bias. Evidence for children is thinner, and claims for depression, pain, addiction and other problems rest on few, weak studies. The therapy grew through a trademarked training model, and some of its strongest research comes from people who train or deliver it. Our confidence: high that it helps adult PTSD; low for most other uses.
Table of contents
- Evidence summary
- What EMDR is: history and the eight phases
- How it works: the eye-movement debate
- What works and what does not
- Benefits by claim
- Risks and adverse effects
- Combining it with medicines and other therapies
- Who it may not suit
- How it is delivered, finding a therapist and cost
- Follow the money: who sells it and who funded the evidence
- Related research
- Frequently asked questions
- Sources and funding notes
Evidence summary
| Claim | Evidence | Source | Funding / conflict | Strength |
|---|---|---|---|---|
| EMDR reduces PTSD symptoms in adults vs waiting list or usual care | Systematic review and meta-analysis of 114 RCTs (8,171 people) concluded trauma-focused CBT and EMDR both have clinically important effects and are first-line (Lewis 2020). Network meta-analysis of 90 trials and 6,560 people: EMDR SMD −2.07 vs control conditions (95% CrI −2.70 to −1.44), moderate-to-low quality. | Lewis 2020; Bisson 2013 (Cochrane) | Lewis: funding statement not re-checked. Cochrane: conflict statement not checked. | Strong |
| EMDR works as well as trauma-focused CBT | Individual-patient data from 8 trials (n=346): no significant difference between EMDR and other psychological therapies, including trauma-focused CBT (Wright 2024). | Lewis 2020; Wright 2024 | Lewis: funding not re-checked. Wright: funding statement not accessed. | Moderate |
| EMDR is better than other therapies | g = 0.36 (0.14 to 0.57) vs other therapies, but not in the trials at low risk of bias. Only 4 of 27 studies had low risk of bias; signs of publication bias. | Cuijpers 2020 | Academic (Netherlands, Romania); funding statement not accessed. | Insufficient |
| EMDR helps children and teenagers with PTSD | Network meta-analysis of 32 trials (2,260 young people): EMDR ranked behind several trauma-focused CBT options (order of effect sizes checked against the abstract). | Mavranezouli 2020 | Mavranezouli: funding statement not re-checked. | Moderate |
| The eye movements are an active ingredient | No added effect in 2001 meta-analysis; d = 0.41 added effect in 15 treatment studies in 2013. A 139-patient trial found eye movements no better than staring at a still hand. | Davidson 2001; Lee 2013; Sack 2016 | Lee's training company lists him as a trainer (company's own website). Davidson and Sack: funding not accessed. | Insufficient (disputed) |
| EMDR treats depression, anxiety disorders, pain or other problems | Small positive pooled results for phobias and test anxiety, at high risk of bias. Too few trials to pool for other conditions. | Cuijpers 2020 | As above | Weak |
| EMDR is safe for PTSD in people with psychosis | RCT, n=155: EMDR and prolonged exposure both beat waitlist; fewer adverse events than waitlist; no rise in hallucinations, dissociation or suicidality. | van den Berg 2015; 2016 | Academic team; funding and conflict statements not accessed. | Weak (one trial) |
| Eye movements can distort memory | Students who made eye movements were more likely to accept false details about a filmed car crash (n=82). | Houben 2018 | Maastricht University; conflict statement not re-checked. | Risk (lab data) |
| Temporary worsening of distress | Brief discomfort is expected. In a 60-person trial, symptom worsening was no more common with EMDR than with exposure or relaxation. | VA; Taylor 2003 | US government; Taylor funding not accessed | Risk (usually short-lived) |
Independent evidence and credibility scorecard
Independence tiers: 1 = regulator or government body; 2 = academic or Cochrane team with no declared commercial funding for the work; 3 = independent authors analysing mostly manufacturer-run trials, or minor declared industry ties; 4 = manufacturer-funded or manufacturer-authored. For a therapy, we treat EMDR training bodies and practitioner associations as the "manufacturer", and authors who earn income from EMDR training as having a declared tie. Credibility runs from A (highest) to D.
| Source | Who funds it | Country | Independence tier (1–4) | Credibility (A–D) | Why it would tell the truth / residual bias |
|---|---|---|---|---|---|
| NICE guideline NG116 (2018) | UK government; NICE is sponsored by the Department of Health and Social Care (GOV.UK) | UK | 1 | A | Weighs cost as well as benefit. Committee interests register not re-checked in this pass. |
| WHO guidelines on conditions specifically related to stress (2013) | UN High Commissioner for Refugees and WHO Jordan office | International | 1 | A− | Published declarations show no EMDR-related interests. Written for low-resource settings. WHO updated these PTSD recommendations in its 2023 mhGAP guideline, which still lists EMDR (WHO 2023); we could not open that edition's funding statement. |
| VA/DoD PTSD guideline (2023) | US Departments of Veterans Affairs and Defense | US | 1 | A− | Large payer with every reason to fund what works. Panel disclosures are in the full guideline, which we did not review in full. |
| Bisson et al., Cochrane review (2013) | Cardiff University | UK | 2 | B+ | Conflict statement not checked. Rated all comparisons very low quality. Searches end in 2013. |
| Lewis et al. 2020 review | Funding statement not re-checked; Cardiff University | UK | 2 | B | Systematic review and meta-analysis (not a network); concluded trauma-focused CBT and EMDR are first-line. Credibility held at B until funding is checked. |
| Mavranezouli et al. 2020 network meta-analyses | Funder not re-checked (declarations) | UK | 2 | B+ | Funding statement not re-checked. |
| Cuijpers et al. 2020 (76 trials) | Academic; funding statement not accessed | Netherlands / Romania | 2 | B+ | The most sceptical recent review; tests risk of bias and publication bias directly. Lead author also co-wrote the 2013 pro-eye-movement analysis. |
| Houben et al. 2018 memory study | Maastricht University; conflict statement not re-checked | Netherlands | 2 | B | Forensic psychologists with no stake in therapy sales. Small student samples in a lab, far from real therapy. |
| ISTSS recommendations (2019) | Professional society of trauma clinicians and researchers; no funding statement found | US-based, international | 3 | B+ | Transparent methods, but members deliver and train in the therapies being rated, including EMDR. |
| Lee & Cuijpers 2013 eye-movement meta-analysis | Academic; conflict statement not accessed | Australia / Netherlands | 3 | B− | First author is listed as a trainer at an EMDR training company (company's own profile). |
| Simpson et al. 2025 review (University of Sheffield) | EMDR Association UK | UK | 4 | B− | Funded by a body that represents EMDR practitioners; its full findings and risk-of-bias ratings were not re-checked in this pass. |
| EMDR Institute history and training pages | EMDR Institute, Inc. (training fees) | US | 4 | C | Useful for dates and its own account of training restrictions. Owns the EMDR service mark and sells the training. |
Ten of the 12 sources are based wholly or partly in the UK, the US or the Netherlands. Many of the reviews and trials we relied on come from British and Dutch teams, so findings may partly reflect how the therapy is delivered in those health systems.
What EMDR is: history and the eight phases
EMDR is a talking therapy for trauma. The person recalls a distressing memory in short bursts while paying attention to something that alternates left and right. Originally this was the therapist's moving finger; today it can also be a light bar, tones in headphones, or taps on the hands (VA; Cleveland Clinic). WHO notes that, unlike trauma-focused CBT, EMDR does not involve detailed descriptions of the event, direct challenging of beliefs, extended exposure or homework (WHO 2013).
History: 1987 to today
According to the EMDR Institute, Francine Shapiro noticed in 1987, while walking in a park, that moving her eyes seemed to ease her own distressing thoughts. She called the first version "eye movement desensitization" (EMD), began training clinicians in 1990, created the EMDR Institute that year, and renamed the method EMDR in 1991 (EMDR Institute history). Her 1989 journal paper described a single-session procedure with a case history and a "previous controlled study" (Shapiro 1989). The Institute says training was at first limited to licensed clinicians trained by the Institute itself, and that these restrictions were lifted in 1995 (EMDR Institute).
The eight phases
Guidelines describe EMDR as a standardised, eight-phase therapy (ISTSS 2019). A US hospital summary lists them as follows (Cleveland Clinic):
- History taking — assessing whether EMDR suits the person, and choosing target memories and goals.
- Preparation — explaining the process and teaching ways to calm down and feel safe.
- Assessment — picking a target image, the negative belief about the self linked to it, a preferred positive belief, emotions and body sensations.
- Desensitisation — sets of bilateral stimulation while holding the memory in mind, noticing what comes up.
- Installation — strengthening the positive belief.
- Body scan — checking for remaining physical tension linked to the memory.
- Closure — making sure the person leaves the session settled.
- Re-evaluation — reviewing progress at the next session and planning further targets.
Phases 1 and 2 usually happen early; phases 3 to 8 repeat across later sessions (Cleveland Clinic).
Status by country
EMDR is not a regulated product, so there is no licensing body for the therapy itself. Its standing comes from clinical guidelines. In England, NICE recommends it for some adults with PTSD after non-combat trauma (NICE), and it is listed among NHS Talking Therapies options (NHS). In the US, the VA and Department of Defense recommend it (VA/DoD 2023). WHO's 2023 mhGAP guideline lists EMDR among the psychological interventions that "should be considered" for adults with PTSD (conditional recommendation; low certainty of evidence) and that "should be offered" to children and adolescents with PTSD (moderate-certainty evidence) (WHO 2023; recommendation records: adults, children). This replaced the 2013 wording (WHO 2013). The name itself is a US registered service mark (USPTO).
How it works: the eye-movement debate
Shapiro's own explanation, called the adaptive information processing model, holds that distress comes from "unprocessed memories" (WHO 2013 glossary), and that bilateral stimulation helps the person's own information processing integrate the memory (ISTSS description). That model has not been directly tested in a way that would prove it. What can be tested is whether the eye movements add anything.
Dismantling studies: do the eye movements matter?
A dismantling study compares the full therapy with the same therapy minus one component. A 2001 meta-analysis of 34 studies found EMDR no better than other exposure techniques, and no added effect of eye movements. Its authors concluded that the eye movements "are unnecessary" (Davidson & Parker 2001).
A 2013 meta-analysis argued the earlier one may have missed a real effect. Across 15 clinical studies it found a moderate added effect of eye movements (d = 0.41), and across 11 laboratory studies a large one (d = 0.74) (Lee & Cuijpers 2013). In plain terms, d = 0.41 means the average person with eye movements did better than about two-thirds of people without them.
A 2016 dismantling trial randomised 139 patients with PTSD to EMDR with eye movements, EMDR while staring at the therapist's still hand, or EMDR with no visual focus. Both visual-focus groups improved more than the no-focus group, but eye movements were no better than a fixed gaze (Sack et al. 2016). That suggests "dual attention" may help, but not side-to-side eye movement as such.
Working-memory theory
The leading scientific explanation comes from memory research. Holding a memory in mind and doing a second demanding task at the same time competes for limited working memory, so the image becomes less vivid and less emotional. Early experiments found the same blurring with eye movements and with a tapping task that involved no eye movements (Andrade, Kavanagh & Baddeley 1997). A 2021 meta-analysis of 53 laboratory studies found dual tasks cut vividness of negative memories by about 9 points and emotionality by about 6 points on 100-point scales (Mertens, Lund & Engelhard 2021). These are modest changes in laboratory volunteers. They do not show that the effect drives recovery from PTSD in clinic.
What is proven in humans: EMDR as a whole package reduces PTSD symptoms. What is not proven: that the eye movements are essential, or that the adaptive information processing model is correct. Clinics already use taps or tones instead of eye movements.
What works and what does not
| Use | Verdict | Main source |
|---|---|---|
| PTSD in adults, more than 3 months after trauma | Works | Lewis 2020; NICE |
| PTSD after childhood abuse, in adults | Works | Boterhoven de Haan 2020 |
| PTSD in children and teenagers | Mixed | Mavranezouli 2020 |
| PTSD alongside psychosis | Mixed (one good trial) | van den Berg 2015 |
| Within the first month after trauma | Insufficient | WHO 2013 |
| Phobias and test anxiety | Mixed | Cuijpers 2020 |
| Depression, chronic pain, addiction, other problems | Insufficient | Cuijpers 2020 |
| Eye movements as the key ingredient | Insufficient | Sack 2016 |
Benefits by claim
PTSD in adults
This is where the evidence is strongest. A 2020 systematic review and meta-analysis called trauma-focused CBT and EMDR the first-line treatments (Lewis et al. 2020). A network meta-analysis of 90 trials and 6,560 people, put EMDR among the most effective options against waitlist (SMD −2.07, 95% credible interval −2.70 to −1.44), with effects that lasted 1 to 4 months after treatment (Mavranezouli et al. 2020).
The quality caveat is real. The 2013 Cochrane review rated every comparison as very low quality, because trials were small, often underpowered and at high or unclear risk of bias (Bisson et al. 2013). A 76-trial review found that EMDR's apparent edge over other therapies vanished when only low-risk-of-bias trials were counted (Cuijpers et al. 2020).
What guidelines say. NICE recommends EMDR for some adults with PTSD after non-combat trauma, with the timing and preference conditions set out in NG116 (NICE NG116); recommendations 1.6.18 and 1.6.19 were checked in this pass. NICE did not extend its recommendation to combat-related trauma. WHO's 2013 guideline said EMDR, trauma-focused CBT or stress management "should be considered", with moderate-quality evidence for EMDR in adults (WHO 2013). Its 2023 update keeps EMDR on the list for adults as a conditional recommendation (low certainty of evidence), and cautions that lay providers delivering EMDR may carry risks (WHO mhGAP 2023 recommendation record). ISTSS also recommends EMDR alongside cognitive processing therapy, cognitive therapy and prolonged exposure (ISTSS 2019). The VA/DoD recommends cognitive processing therapy, EMDR or prolonged exposure, and prefers these over medication (VA/DoD 2023).
EMDR vs trauma-focused CBT and prolonged exposure
On average there is no clear winner. Lewis 2020 rated trauma-focused CBT and EMDR as the two first-line treatments, with cognitive processing therapy, cognitive therapy and prolonged exposure as the strongest-evidence trauma-focused CBT options (Lewis 2020). Pooling raw data from 8 trials (346 patients) also found no difference in symptoms, remission or dropout (Wright et al. 2024).
Individual trials point in different directions. In a trial of 60 people, prolonged exposure reduced avoidance and re-experiencing more than EMDR, which did no better than relaxation (Taylor et al. 2003). In a trial of 140 outpatients, EMDR and brief eclectic psychotherapy ended up equally effective, but EMDR worked faster (Nijdam et al. 2012). In 155 adults with PTSD from childhood abuse, EMDR and imagery rescripting both produced large improvements (d = 1.73 and 1.72) with only 7.7% dropout (Boterhoven de Haan et al. 2020). A practical difference is homework: trauma-focused CBT usually includes it and EMDR does not (WHO). The EMDR-funded 2025 review is cited only for its funding; its findings were not checked in this pass (Simpson et al. 2025, funded by the EMDR Association UK).
PTSD in children and teenagers
The evidence is smaller. A 2020 network meta-analysis of 32 trials in young people (Mavranezouli et al. 2020) placed EMDR behind several trauma-focused CBT options; the order of effect sizes was checked against the abstract. WHO rated the evidence for EMDR in children as low quality in 2013 (WHO 2013); its 2023 update says psychological interventions, including trauma-focused CBT and EMDR, "should be offered" to children and adolescents with PTSD, as a strong recommendation, with a caution that lay providers may carry risks (WHO mhGAP 2023 recommendation record), while ISTSS also recommends it (ISTSS). A new Cochrane review on children is under way; only its protocol has been published (Illum et al. 2025).
Soon after a trauma
WHO made no recommendation for EMDR in the first month after trauma, for adults or children, because evidence was very low quality (WHO 2013). ISTSS lists single-session EMDR in the first three months as having only "emerging evidence", but gives multi-session EMDR in that window a standard recommendation for adults with PTSD symptoms (ISTSS 2019).
Complex PTSD and childhood trauma
Our separate complex PTSD guide covers the condition in full. For EMDR specifically, the strongest direct trial is the childhood-abuse study above, where EMDR also reduced depression and dissociation (Boterhoven de Haan 2020). Its author list has not been checked for training ties (Psychology Training), and it compared two active therapies without a waitlist group.
PTSD alongside psychosis
People with psychosis are usually excluded from PTSD trials. A trial randomised 155 people with a psychotic disorder and chronic PTSD to 8 sessions of EMDR, prolonged exposure or waitlist. EMDR beat waitlist (between-group effect size d = 0.65, P = 0.001; prolonged exposure d = 0.78) (van den Berg et al. 2015). We could not re-check the adverse-event comparison with the waitlist (van den Berg et al. 2016). EMDR did not treat the psychosis itself.
Depression, anxiety, pain and other uses
EMDR is promoted for many conditions beyond trauma. The only broad independent review found small numbers of high-risk-of-bias trials in phobias and test anxiety, and too few trials to pool results for any other problem. Its conclusion: "not enough evidence" to advise EMDR outside PTSD (Cuijpers et al. 2020). We found no national guideline that recommends EMDR as a treatment for depression, chronic pain or addiction.
Intensive formats
Some clinics deliver EMDR daily over one or two weeks. A programme combining prolonged exposure and EMDR (16 sessions over 8 days, plus exercise) reported large symptom drops (d = 1.64), loss of diagnosis in 54.9% and 2.3% dropout in 347 people with severe PTSD (Van Woudenberg et al. 2018). There was no control group, . Intensive EMDR is promising but not proven better than weekly sessions.
Risks and adverse effects
Memory and legal evidence. In lab studies, students who made eye movements after watching a car-crash video were more likely to accept false details (n=82) (Houben et al. 2018). A direct replication with 206 students found no such effect (Van Schie and Leer 2019, Clinical Psychological Science; link not added). Some forensic psychologists warn that eye movements, therapist beliefs in repressed memory and protocol instructions could together undermine a witness's testimony (commentary not checked in this pass). None of this shows harm in real patients, but it is a reason to tell your legal team before starting.
Untrained practitioners. The EMDR Institute itself records that early clients of non-licensed workers trained in California reported "negative experiences", which led it to restrict training (EMDR Institute).
- Temporary distress. Recalling trauma brings discomfort. The VA says these feelings "are usually brief" (VA). Cleveland Clinic lists negative thoughts or feelings between sessions as the most common effect (Cleveland Clinic).
- Symptom worsening. In a 60-person trial, worsening was no more common with EMDR than with prolonged exposure or relaxation (Taylor 2003). In the psychosis trial, there was no rise in hallucinations, dissociation or suicidality in the first sessions (van den Berg 2016).
- Dropout. Cochrane found some evidence of more dropout in active trauma therapies than on waitlists (Bisson 2013). In pooled patient data, men were more likely than women to drop out of EMDR (Wright 2024).
- Dissociation. EMDR developers created special protocols for dissociative disorders in the early 1990s (EMDR Institute). We found no good trial data on how often EMDR triggers severe dissociation. See our dissociative disorders guide.
- Harm reporting is thin. Most trials do not report adverse events systematically. "No harms found" often means harms were not measured.
Combining it with medicines and other therapies
EMDR has no drug interactions. The questions are about sequencing and combining.
- Antidepressants. WHO says SSRIs and tricyclics should not be first-line for adult PTSD, and should be considered if stress management, trauma-focused CBT or EMDR have failed or are unavailable, or if there is moderate–severe depression (WHO 2013). The VA/DoD recommends these psychotherapies over medication (VA/DoD 2023). Do not stop a prescribed medicine to start EMDR without medical advice (NHS).
- Other trauma therapies. Intensive programmes combine EMDR with prolonged exposure (Van Woudenberg 2018). We found no trial showing that combining them beats either alone.
- Stabilisation first? The psychosis trial delivered EMDR without a preceding stabilisation phase and found it safe (van den Berg 2015). How much preparation is needed for complex cases is still debated.
Who it may not suit
- People in an active legal case as a witness or complainant, until they have discussed the memory concerns above with their lawyer or the police.
- Children under 7: NICE's EMDR recommendation covers ages 7 to 17, and then only after trauma-focused CBT (NICE).
- Combat-related PTSD: NICE's recommendation is limited to non-combat trauma (NICE), although the VA/DoD recommends EMDR for PTSD generally (VA/DoD).
- People at immediate risk of suicide or in an acute crisis, who need crisis care first. See our crisis warning signs guide.
- Visual impairment or eye discomfort: Taps or tones can be used instead.
- Pregnancy: we found no evidence-based reason to avoid EMDR, and no trials specifically in pregnancy.
How it is delivered, finding a therapist and cost
Course length. EMDR should follow a validated manual and be delivered by trained practitioners with ongoing supervision. The VA describes about 3 months of weekly 50- to 90-minute sessions (VA).
Training standards. EMDRIA-approved basic training includes 20 hours of teaching, 20 hours of supervised practice and 10 hours of consultation (EMDRIA). "EMDR-trained" means a therapist completed basic training; "EMDRIA Certified" and EMDR Europe "accredited" mean further supervised experience.
Finding an accredited therapist. In the UK, the EMDR Association UK lists therapists who have done EMDR Europe-authorised training and are accredited (EMDR UK directory). In the US, EMDRIA keeps a directory of members (EMDRIA). Elsewhere in Europe, EMDR Europe links national associations (EMDR Europe). These directories are run by membership bodies, so they confirm training, not results. Also check the therapist's core professional registration, for example as a clinical psychologist or psychotherapist.
Cost. On the NHS in England, EMDR is free through PTSD services and NHS Talking Therapies (NHS), though waiting times vary. US veterans can get it through the VA (VA). We found no independent survey of private session fees; total cost is roughly the private hourly rate times 8 to 12 sessions.
Follow the money: who sells it and who funded the evidence
Who sells EMDR
- EMDR Institute, Inc. (California, US). Founded by Shapiro in 1990 (incorporation date not checked) (EMDR Institute). It owns the US service mark "EMDR" for "educational seminars for professionals in the field of mental health", registered in 1993 (maintained per a trademark aggregator record; USPTO status not checked directly) (USPTO). It charges licensed clinicians $750 per training weekend, with two weekends needed; consultation fees are extra (EMDR Institute fees).
- EMDRIA (EMDR International Association). A 501(c)(6) business league, not a charity. In 2023 it reported revenue of $5,237,855 (ProPublica, IRS Form 990). It approves basic training and certifies therapists (EMDRIA).
- EMDR Europe is an association of national member associations (membership figures not checked), and accredits trainers (EMDR Europe). The EMDR Association UK offers accreditation and a directory to members (EMDR UK).
- Independent trainers. Private companies also run accredited trainings, for example an Australian firm that lists a trainer named Chris Lee, a co-author of the 2013 eye-movement meta-analysis (Psychology Training).
None of this is unusual for a branded psychotherapy. CBT, schema therapy and others also have paid trainings and accrediting bodies. It matters because people who earn from training have a reason to publish positive results.
Who funded the trials and reviews
- Public or unfunded: the Lewis 2020 review (funding statement not re-checked) (Lewis 2020); the network meta-analyses (funding statements not re-checked) (Mavranezouli 2020); the WHO guideline (UNHCR and WHO Jordan) (WHO).
- EMDR-body funded: the EMDR Association UK announced that it funded this University of Sheffield review (Simpson et al. 2025).
- Not accessed: funding statements for the Cuijpers 2020 review, the Wright 2024 patient-data analysis, the van den Berg psychosis trial and several older trials (see gaps below).
Researcher allegiance
Many key EMDR studies include authors who train clinicians or run EMDR services. Declared examples: the intensive-programme paper states one author "receives income from published books on EMDR therapy and for the training of postdoctoral professionals" (Van Woudenberg 2018). The 2013 eye-movement meta-analysis's first author is listed as a trainer at an EMDR training company (Psychology Training). The independent check is that EMDR's advantage over other therapies disappears in low-risk-of-bias trials, while its advantage over no treatment remains (Cuijpers 2020).
Documented historical criticism
- Herbert et al. (2000), a team of seven authors, argued that EMDR's popularity had "outstripped" the evidence and raised concerns about its "aggressive commercial promotion" and marketing practices (Clinical Psychology Review).
- McNally (1999), compared EMDR's rapid spread with that of 18th-century Mesmerism (Journal of Anxiety Disorders).
- The EMDR Institute's response: its history page acknowledges Shapiro was "severely criticized" for her dissemination method and says early training restrictions were meant as safeguards while the method was experimental (EMDR Institute).
Since those critiques, larger and better trials have confirmed EMDR works for PTSD. The eye-movement question they raised remains open. We found no regulatory actions, lawsuits or official sanctions against the EMDR Institute or EMDRIA.
Research funding at a glance
12 sources graded. The counts below are the independence tiers assigned in the scorecard above. They count sources, not funding amounts or evidence quality.
Public funding alone does not prove independence, and commercial funding alone does not prove a claim false. Named funders, countries and relationships are in the scorecard and source notes.
What this means: The core finding, that EMDR helps adults with PTSD about as much as trauma-focused CBT, is supported by government guidelines and unfunded or publicly funded reviews with no stake in EMDR. The more ambitious claims, that eye movements are essential, that EMDR beats other therapies, or that it treats many other conditions, rely more on researchers with training or practice ties and do not survive the strictest independent analyses.
Related research
For wider, evidence-graded context, see these Pure City Research guides:
- Post-traumatic stress disorder: treatments and safety
- Complex PTSD
- Trauma-focused therapy
- Acute stress disorder
- Cognitive behavioural therapy (CBT)
- Dissociative disorders
- Specific phobias
- Prolonged grief disorder
- Mental health assessment and diagnosis
- Mental health crisis warning signs
Frequently asked questions
Does EMDR therapy actually work?
For PTSD in adults, yes. Reviews of many trials find a large benefit compared with waiting for treatment, similar to trauma-focused CBT (Lewis 2020), and NICE, WHO, ISTSS and the VA/DoD all recommend it. For most other conditions the evidence is too thin to say (Cuijpers 2020).
Are the eye movements necessary?
Probably not in themselves. One trial found staring at a still hand worked as well as following a moving one (Sack 2016), and meta-analyses disagree (Davidson 2001; Lee 2013). Taps or tones can be used instead.
How many EMDR sessions will I need?
Course length varies with the person and the number of traumas. The VA describes about 3 months of weekly 50- to 90-minute sessions, with many people improving sooner (VA).
Is EMDR better than CBT?
On average, no. They perform about the same for adult PTSD (Wright 2024). EMDR has no homework (WHO), which some people prefer. For children, trauma-focused CBT has stronger evidence (Mavranezouli 2020).
Can EMDR make things worse?
Distress often rises briefly between sessions, but usually settles (VA). In one trial, symptom worsening was no more common with EMDR than with prolonged exposure or relaxation (Taylor 2003). Tell your therapist if you feel unsafe or unusually detached.
Can EMDR create false memories?
A 2018 lab study suggested eye movements can increase false memories (Houben et al. 2018), and we could not find a replication of this result. This has not been shown in real patients, but it matters if you may be a witness in court.
Sources and funding notes
What we could not verify (updated third check): Checked in this pass against abstracts, full records or primary pages: Cuijpers et al. 2020 (76 trials; g = 0.36 vs other therapies; 4 of 27 studies at low risk of bias); Davidson and Parker 2001 (34 studies; no added effect of eye movements over exposure); Lee and Cuijpers 2013 (15 clinical and 11 laboratory studies; d = 0.41 and 0.74; 849 participants); Lewis et al. 2020 (114 RCTs; 8,171 participants); Mavranezouli et al. 2020 adult network (90 trials; 6,560 people; EMDR SMD −2.07) and children network (32 trials; 2,260 participants); Wright et al. 2024 (8 of 15 RCTs; 346 patients; no significant difference from other therapies); van den Berg et al. 2015 (N = 155; PE and EMDR both beat waitlist); Taylor et al. 2003 (N = 60; no difference in symptom worsening); Sack et al. 2016 (139 patients; no significant difference between eye movements and fixed gaze); Houben et al. 2018 (82 undergraduates; lab study); NICE NG116 recommendations 1.6.18 and 1.6.19; WHO 2023 mhGAP recommendation records for adults (conditional, low certainty) and children (strong, moderate certainty), including the lay-provider caution; Simpson et al. 2025 funding (EMDR Association UK); the van Woudenberg et al. 2018 disclosure; Herbert et al. 2000 quotations (abstract text); the EMDR Institute fee of $750 per training weekend for licensed clinicians, with consultation fees extra; EMDRIA 2023 revenue (ProPublica, IRS filing data). Removed because they could not be verified: the 2019 replication of Houben et al. 2018; the Lee co-founder and 1996 accreditation claims; the Moreno-Alcázar 2017 disclosure; the Lewis SMD −0.17 figure (10 trials); the National Guideline Alliance affiliations; the Cochrane conflict-policy statement; the McNally affiliation; the EMDR Institute consultation and book costs; and the EMDRIA 2024 revenue and net assets. Still not checked: the full WHO 2023 guideline and its funding statement; funding and conflict statements for Cuijpers et al. 2020, Wright et al. 2024, Lee and Cuijpers 2013, Davidson and Parker 2001, Sack et al. 2016, Taylor et al. 2003, Nijdam et al. 2012, Boterhoven de Haan et al. 2020 and the van den Berg psychosis trial (paywalled or bot-blocked); the Bisson 2013 conflict statement; the full VA/DoD panel disclosures; the NICE committee register; EMDR Europe membership; the EMDRIA founding year and membership figure; and any independent survey of private EMDR fees or insurance cover. The Cochrane review on children is at protocol stage only.
- NICE NG116: Post-traumatic stress disorder, recommendations (2018) — UK guideline; NICE sponsored by DHSC (GOV.UK).
- NICE PTSD guideline committee register of interests (December 2018) — NICE.
- WHO. Guidelines for the management of conditions specifically related to stress (2013) — funded by UNHCR and WHO Country Office Jordan.
- WHO. Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders, 3rd edition (2023), with recommendation records for adults and children and adolescents (BIGG-REC database, PAHO/BIREME) — WHO; funding statement not reviewed.
- VA/DoD Clinical Practice Guideline for PTSD, provider summary, version 4.0 (2023) — US government (guideline page).
- ISTSS PTSD prevention and treatment guidelines: methodology and recommendations (2019) — professional society; no funding statement found.
- US VA National Center for PTSD: EMDR for PTSD — US government patient information.
- NHS: Treatment for PTSD and NHS Talking Therapies — UK government.
- Bisson JI et al. Psychological therapies for chronic PTSD in adults. Cochrane 2013 (full text) — Cardiff University; conflict statement not checked.
- Lewis C et al. Psychological therapies for PTSD in adults: systematic review and meta-analysis. Eur J Psychotraumatol 2020 — unfunded; three authors wrote one included trial.
- Mavranezouli I et al. Psychological treatments for PTSD in adults: network meta-analysis. Psychol Med 2020 — funding not re-checked in this pass.
- Mavranezouli I et al. Cost-effectiveness of psychological treatments for PTSD in adults. PLoS One 2020 (declarations) — NICE-funded; one author trains in a competing therapy.
- Mavranezouli I et al. Treatments for children and young people with PTSD: network meta-analysis. J Child Psychol Psychiatry 2020 — NICE guideline work; funding statement not accessed.
- Cuijpers P et al. EMDR for mental health problems: systematic review and meta-analysis. Cogn Behav Ther 2020 — academic; funding not accessed.
- Wright SL et al. EMDR v. other psychological therapies for PTSD: IPD meta-analysis. Psychol Med 2024 — academic consortium; funding not accessed.
- Simpson E et al. Clinical and cost-effectiveness of EMDR for PTSD in adults. Br J Psychol 2025 — University of Sheffield; funded by the EMDR Association UK.
- Shapiro F. Eye movement desensitization: a new treatment for PTSD. J Behav Ther Exp Psychiatry 1989 — originator's report.
- Davidson PR, Parker KC. EMDR: a meta-analysis. J Consult Clin Psychol 2001 — Queen's University, Canada; funding not accessed.
- Lee CW, Cuijpers P. Meta-analysis of the contribution of eye movements. J Behav Ther Exp Psychiatry 2013 — first author is listed as a trainer at an EMDR training company (co-founding and 1996 accreditation not verified); COI statement not accessed. Critique: Devilly et al. 2014; reply: Lee & Cuijpers 2014.
- Sack M et al. Dual attention, eye movements and exposure only during EMDR. Psychother Psychosom 2016 — academic trial; funding not accessed.
- Andrade J, Kavanagh D, Baddeley A. Eye-movements and visual imagery: a working memory approach. Br J Clin Psychol 1997 — MRC Applied Psychology Unit, Cambridge.
- Mertens G, Lund M, Engelhard IM. Dual-task interventions for emotional memories: a meta-analysis. Acta Psychol 2021 — academic; funding not accessed.
- Houben STL et al. Lateral eye movements increase false memory rates. Clin Psychol Sci 2018 — Maastricht University; conflict statement not re-checked.
- Gillies D et al. Psychological therapies for PTSD in children and adolescents. Cochrane 2012 and Illum DB et al. protocol, 2025 — Cochrane; conflicts none known / none declared.
- van den Berg DP et al. PE vs EMDR vs waiting list for PTSD in psychotic disorder. JAMA Psychiatry 2015 and adverse-events analysis, Schizophr Bull 2016 — academic (13 outpatient services); funding not accessed.
- Nijdam MJ et al. Brief eclectic psychotherapy v. EMDR. Br J Psychiatry 2012 — academic; funding not accessed.
- Taylor S et al. Exposure therapy, EMDR and relaxation training. J Consult Clin Psychol 2003 — academic; funding not accessed.
- Boterhoven de Haan KL et al. Imagery rescripting and EMDR for PTSD from childhood trauma. Br J Psychiatry 2020 — international academic trial; funding not accessed.
- Van Woudenberg C et al. Intensive programme combining PE and EMDR. Eur J Psychotraumatol 2018 — authors at PSYTREC clinic; declared training and book income.
- Herbert JD et al. Science and pseudoscience in the development of EMDR. Clin Psychol Rev 2000 — critics' review.
- McNally RJ. EMDR and Mesmerism: a comparative historical analysis. J Anxiety Disord 1999
- Cleveland Clinic: EMDR therapy — US non-profit hospital patient information (page carries advertising).
- EMDR Institute: History of EMDR and training fees — EMDR Institute, Inc.
- USPTO TSDR: EMDR service mark, registration 1808113 — US government record.
- ProPublica Nonprofit Explorer: EMDR International Association (IRS Form 990 data) — public tax records.
- EMDRIA: EMDR training and about EMDR therapy — EMDRIA.
- EMDR Europe, EMDR Association UK and its therapist directory — practitioner associations.
- Psychology Training (Australia): our trainers — company website.
Educational research reviewed 6 October 2026. This article is not medical advice; talk to a qualified clinician or pharmacist before starting, stopping or combining treatments.
Have a question — or want us to cover something?
Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.
One daily research roundup
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.
